| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2018 | MTD Mettler Toledo International Inc/ | Donnelly William P | Executive Vice President | Sell | 500 | $585.00 | $292,500.00 | -33.3% | |
| Aug 9, 2018 | VCYT Veracyte, Inc. | Hall Christopher M | President And COO | Sell | 20,000 | $12.00 | $240,000.00 | -38.1% | |
| Aug 8, 2018 | RVTY Revvity, Inc. | Sullivan Patrick J | Director | Sell | 12,672 | $86.19 | $1,092,263.04 | -24.6% | |
| Aug 8, 2018 | MTD Mettler Toledo International Inc/ | Donnelly William P | Executive Vice President | Sell | 1,500 | $587.67 | $881,500.00 | -42.9% | |
| Aug 7, 2018 | WST West Pharmaceutical Services Inc | Flynn Karen | Sr VP &Chief Commercial Offic | Sell | 20,458 | $116.23 | $2,377,833.34 | -48.7% | |
| Aug 7, 2018 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 138,105 | $57.06 | $7,880,271.30 | -28.2% | |
| Aug 6, 2018 | RVTY Revvity, Inc. | Lopardo Nicholas A | Director | Sell | 3,505 | $85.60 | $300,028.00 | -6.2% | |
| Aug 6, 2018 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chief Executive Officer | Sell | 50,000 | $233.95 | $11,697,618.72 | -5.5% | |
| Aug 6, 2018 | MTD Mettler Toledo International Inc/ | Donnelly William P | Executive Vice President | Sell | 3,000 | $590.07 | $1,770,200.00 | -42.9% | |
| Aug 6, 2018 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 731,460 | $59.26 | $43,344,976.43 | -26.9% | |
| Aug 2, 2018 | IQV Iqvia Holdings Inc. | Parks Robert | Sr Vice President, Controller | Sell | 871 | $124.34 | $108,303.59 | -23.0% | |
| Aug 2, 2018 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Chairman And CEO | Sell | 14,950 | $11.50 | $171,925.00 | -22.2% | |
| Aug 2, 2018 | MEDP Medpace Holdings, Inc. | Geiger Jesse J60 | CFO &COO, Lab Operations | Sell | 7,407 | $60.15 | $445,531.05 | -100% | |
| Aug 2, 2018 | RVTY Revvity, Inc. | Okun Andrew76 | Please See Remarks | Sell | 14,045 | $82.18 | $1,154,218.10 | -61.3% | |
| Aug 2, 2018 | RVTY Revvity, Inc. | Goldberg Joel S58 | Please See Remarks | Sell | 34,608 | $85.00 | $2,941,680.00 | -35.7% | |
| Aug 2, 2018 | RVTY Revvity, Inc. | Friel Robert F | President And CEO | Sell | 218,579 | $81.60 | $17,836,032.11 | -16.0% | |
| Aug 1, 2018 | TMO Thermo Fisher Scientific Inc. | Durbin Patrick M | Senior Vice President | Sell | 20,550 | $233.87 | $4,806,043.05 | -9.1% | |
| Aug 1, 2018 | CDNA Caredx, Inc. | King Sasha77 | Chief Commercial Officer | Sell | 9,458 | $14.03 | $132,734.52 | -12.7% | |
| Aug 1, 2018 | VCYT Veracyte, Inc. | Treu Jesse I | Director | Sell | 500,000 | $10.83 | $5,413,600.00 | -9.6% | |
| Aug 1, 2018 | NEO Neogenomics Inc | Jones Steven C | Executive Vice President | Sell | 203,500 | $14.00 | $2,849,411.00 | -2.7% | |
| Jul 31, 2018 | DHR Danaher Corp /de/ | Rales Mitchell P70 | Chairman Of Exec. Committee | Buy | 1,080 | $102.32 | $110,505.60 | +4.3% | |
| Jul 31, 2018 | DHR Danaher Corp /de/ | Joyce Thomas Patrick Jr | President And CEO | Sell | 104,913 | $101.88 | $10,688,506.62 | -23.4% | |
| Jul 30, 2018 | EXAS Exact Sciences Corp | Doyle James Edward75 | Director | Sell | 1,318 | $58.86 | $77,577.48 | -3.4% | |
| Jul 30, 2018 | EXAS Exact Sciences Corp | Carey Thomas D. | Director | Sell | 3,427 | $58.86 | $201,713.22 | -6.5% | |
| Jul 30, 2018 | EXAS Exact Sciences Corp | Zanotti Katherine S50 | Director | Sell | 2,847 | $58.86 | $167,574.42 | -2.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.